Designing for Credibility in Biopharma
Biopharma companies have complicated stories to tell. The science is complex,…
Service Provider Sprawl and the Case for Integrated Commercialization
No two commercialization plans look the same. Unlike other key functions that…
Summer Rhythm: Getting Ready for Fall
Things get pretty intense in the fall. Timelines tighten, board meetings…
The Identity Crisis at the Heart of Medical Affairs
Medical Affairs — the function that translates clinical evidence for…
Your Launch Plan Is Ready. Your Launch Team Isn’t.
Most biotech leaders understand that launch preparation, building the plan, begins well before expected approval. That's not the problem we see.
Process Unleashes Innovation
Strategic planning within a company must be interconnected, with a clear hierarchy that aligns every effort with the overarching vision and mission.
Mind vs. Machine in Asset Strategy
A well-informed asset strategy is an essential component of developing a novel therapy to meet critical patient needs.
Medical Affairs Today
The biggest risk for pre-commercial companies is being singularly focused on a lean development program without planning for the additional data…
The Right Forum, at the Right Time
Some people need to “think out loud.” Others are eager to get right to the point. Toss in challenging schedules and countless communication platforms…
100 Dots Connected: Reflecting on Eight Years of Conversations
The first edition of "Connecting the Dots" was published on September 29, 2017. Since Sue Nemetz penned that inaugural piece, 12 authors from our…
Assuming the Role of Patient
As readers of The NemetzGroup newsletter know, we often use this space to consider progress in biopharma, new technologies, and ways emerging…
The “Forcing Function” of JPM
Biopharma companies need to balance many critical priorities, especially those that are pre-commercial.
Connecting in a Volatile Job Market
What is the correct metaphor for today’s biopharma job market? A roller-coaster? A crater? A dark cloud? A correction?
A Practical Guide to Biopharma Year-End Planning
As summer winds down and vacations (sadly) come to an end, it’s a natural time to shift focus toward the close of the calendar year. Business leaders…